Qualidade de vida visual em pacientes com degeneração macular relacionada à idade neovascular tratados com antiangiogênicos

Qualidade de vida visual em pacientes com degeneração macular relacionada à idade neovascular tratados com antiangiogênicos

INTRODUÇÃO: A degeneração macular relacionada à idade (DMRI) é a principal causa de perda de visão irreversível e cegueira mundialmente. A perda da visão central interfere nas atividades de vida diária, como o reconhecimento facial, leitura e escrita, direção de veículos automotores e em ativida...

Full description

Bibliographic Details
Main Author:	Reinaldo Flávio da Costa Ramalho
Other Authors:	Milton Ruiz Alves
Language:	Portuguese
Published:	Universidade de São Paulo 2018
Subjects:	Acuidade visual Aflibercepte Degeneração macular Doença crônica Qualidade de vida Ranibizumabe Aflibercept Chronic disease Macular degeneration Quality of life Ranibizumab Visual acuity
Online Access:	http://www.teses.usp.br/teses/disponiveis/5/5149/tde-24102018-135624/

Similar Items

Qualidade de vida visual em pacientes com degeneração macular relacionada à idade neovascular tratados com antiangiogênicos
by: Ramalho, Reinaldo Flávio da Costa
Published: (2018)

Comparison of the efficacy of aflibercept and ranibizumab after a 3-month loading dose in patients with diabetic macular edema
by: Murat Çakmaklıoğulları, et al.
Published: (2021-03-01)

Switching to Brolucizumab in Neovascular Age-Related Macular Degeneration Incompletely Responsive to Ranibizumab or Aflibercept: Real-Life 6 Month Outcomes
by: Christof Haensli, et al.
Published: (2021-06-01)

Comparative study between ranibizumab and aflibercept in the management of macular edema caused by diabetes mellitus in age group more than 40 years
by: Abd El-Magid M Tag El-Din
Published: (2019-01-01)

Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab
by: Nixon DR, et al.
Published: (2018-01-01)

Five-year outcomes of intravitreal drug therapy for neovascular age-related macular degeneration in eyes with baseline vision 20/60 or better
by: Khanani AM, et al.
Published: (2019-02-01)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
by: Fouda SM, et al.
Published: (2017-03-01)

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
by: Pessoa B, et al.
Published: (2021-01-01)

Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumab
by: Flora Elwes, et al.
Published: (2018-01-01)

Ranibizumab versus Aflibercept in Macular Edema Secondary to Retinal Vein Occlusion in Real Life: A Retrospective Case Control Study
by: Abdullah Özkaya, et al.
Published: (2017-05-01)

Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab
by: Rachel Hui Fen Lim, et al.
Published: (2017-03-01)

Qualidade de vida relacionada com a visão em pacientes com degeneração macular relacionada à idade neovascular
by: Maria Picoto, et al.
Published: (2015-08-01)

Comparison of 2-Year Outcomes between Intravitreal Ranibizumab and Intravitreal Aflibercept for Diabetic Macular Edema with “Treat-and-Extend” Regimen—Its Usefulness and Problems
by: Shinichiro Chujo, et al.
Published: (2020-09-01)

Real-world outcomes of intravitreal antivascular endothelial growth factors for neovascular age-related macular degeneration in Taiwan: A 4-year longitudinal study
by: Benjamin Chi-Lan Yang, et al.
Published: (2019-01-01)

Anti-VEGF therapy of neovascular age-related macular degeneration: from randomized trials to routine clinical practice
by: R. R. Fayzrakhmanov
Published: (2019-06-01)

Managing Diabetic Macular Edema in Clinical Practice: Systematic Review and Meta-Analysis of Current Strategies and Treatment Options
by: Veritti D, et al.
Published: (2021-01-01)

Investigation of the Trend of Selecting Anti-Vascular Endothelial Growth Factor Agents for the Initial Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
by: Jae-Hui Kim, et al.
Published: (2021-08-01)

A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Alper Halil Bayat, et al.
Published: (2019-12-01)

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion
by: Tagami M, et al.
Published: (2017-02-01)

An efficacy comparison of anti-vascular growth factor agents and laser photocoagulation in diabetic macular edema: a network meta-analysis incorporating individual patient-level data
by: Dominic Muston, et al.
Published: (2018-12-01)

Comparison of two different treatment regimens’ efficacy in neovascular age-related macular degeneration in Turkish population—based on real life data-Bosphorus RWE Study Group
by: Burak Erden, et al.
Published: (2020-01-01)

Cost-consequence analysis of extended loading dose of anti-VEGF treatment in diabetic macular edema patients
by: J. M. Ruiz-Moreno, et al.
Published: (2020-09-01)

Current and Future Anti-VEGF Agents for Neovascular Age-Related Macular Degeneration
by: Kaiser SM, et al.
Published: (2021-09-01)

Short-term results of early switch from Ranibizumab to Aflibercept in poor or non responder age related macular degeneration in clinical practice
by: Luciana de Sá Quirino-Makarczyk, et al.
Published: (2020-05-01)

Satisfação do paciente com degeneração macular relacionada à idade após terapia térmica transpupilar Satisfaction of the patient with age-related macular degeneration after transpupillary thermotherapy
by: Jhony de Polo, et al.
Published: (2004-04-01)

Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizumab
by: Nixon DR, et al.
Published: (2017-04-01)

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials
by: Dugel PU, et al.
Published: (2016-06-01)

Intravitreal ranibizumab and bevacizumab for the treatment of nonsubfoveal choroidal neovascularization in age-related macular degeneration Ranibizumab e bevacizumab intravítreo no tratamento da neovascularização de coróide extrafoveal da degeneração macular relacionada à idade
by: Aaron Brock Roller, et al.
Published: (2009-10-01)

Retinal function determined by flicker ERGs before and soon after intravitreal injection of anti-VEGF agents
by: Gaku Terauchi, et al.
Published: (2019-06-01)

Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
by: Sakanishi Y, et al.
Published: (2017-05-01)

Current approaches to the treatment of diabetic macular edema. A literature review
by: E. V. Bobykin
Published: (2019-04-01)

Management of Macular Edema Secondary to Branch Retinal Vein Occlusion in an Eye with Prior Vitrectomy and Lensectomy
by: Pankaj Malhotra, et al.
Published: (2014-10-01)

Impact of switching from ranibizumab to aflibercept on the number of intravitreous injection and follow up visit in wet AMD: results of real life ELU study
by: Frederic Queguiner, et al.
Published: (2020-02-01)

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
by: Thomas BJ, et al.
Published: (2016-08-01)

A Retrospective Analysis of the Real-Life Utilization of Ranibizumab in Patients with Wet Age-Related Macular Degeneration from Portugal
by: Rufino Silva, et al.
Published: (2017-06-01)

Experiences of using Aflibercept in diabetic macular edema treatment: data from routine clinical practice
by: E. Yu. Santoro
Published: (2018-12-01)

Alternativas terapêuticas para o tratamento da degeneração macular relacionada à idade: um desafio para a saúde pública
by: Humberto Cenci Guimarães, et al.
Published: (2013-10-01)

Alternativas terapêuticas para o tratamento da degeneração macular relacionada à idade: um desafio para a saúde pública
by: Humberto Cenci Guimarães, et al.
Published: (2013-12-01)

Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update
by: Patel PJ, et al.
Published: (2017-11-01)

Two Year Visual Acuity and Structural Outcomes in Patients with Diabetic Macular Oedema Treated with Intravitreal Aflibercept – A Retrospective Cohort Study
by: Kern C, et al.
Published: (2020-02-01)

Cannot write session to /tmp/vufind_sessions/sess_k58ej8q4mqdff98q0aonrrpcu3